Existing investors will also put in $70 million, valuation at $2.5-$2.75 versus $5.4 billion of last year’s pre-IPO round. IPO is shelved f...

The company is investing heavily on improving turnaround time and addressing quality perception of the brand in the market through a combin...

Through strategic acquisitions in the healthcare space, the company seems to be aiming to create “a holistic healthcare ecosystem”. From th...

Under the AstraZeneca-Docon partnership, the Bengaluru-based healthtech startup will equip the identified clinics with customised Electroni...

Thyrocare is making efforts to bolster its brand visibility through the opening of regional and zonal reference laboratories and branded co...

PharmEasy is acquiring a majority stake in diagnostics chain Thyrocare Technologies, in what the online pharmacy claimed was the first ever...

PharmEasy claims to be India’s number one online pharmacy and diagnostics brand. Thyrocare prides itself as the largest diagnostic company.

From Pharmeasy-Thyrocare deal to Twitter briefly locking IT minister's account and China's role in 2021's crypto collapse, here's a quick l...

We outline six common myths that were broken by the pandemic. As we look at the transformations that happened, there is a prescription for ...